http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-46935-U1

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
filingDate 2004-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2005-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2005-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-46935-U1
titleOfInvention MEDICINAL PREVENTIVE PRODUCT BIOSEPTIN
abstract The utility model relates to biotechnology, namely to the production of probiotic biologics in ointment, granular or encapsulated forms. The technical result of the utility model is to increase the effectiveness of the probiotic preparation and expand its scope by creating ointment, granular and encapsulated forms of this drug for the prevention and treatment of diseases of the gastrointestinal tract, skin diseases and urogenital infections. The BIOSEPTIN therapeutic and prophylactic preparation includes a gel base with an active component distributed in its mass, which is used as a biomass of bacteria of the genus Bacillus. In addition, the preparation additionally contains a preservative, as a gel base it contains agar-agar mixed with biomass spores of bacteria of the genus Bacillus, which has a titer in the final preparation of at least! About 6 cells / g, and the finished form of the therapeutic product is made in the form of granules, or placed in a single-use cylindrical hollow detachable capsule, or a container with a lid with the following content of the drug components (wt.%): Preservative 5.0-20.0 agar-agar containing bacteria of the genus Bacillus with a titer of at least 10 6 spores / g, the rest up to 100%. 6 C.p.F., 3 tablets, 3 ill.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2593788-C2
priorityDate 2004-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1390
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11286230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426175422
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1402
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1423
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16399516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24836138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426754013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1423
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260416
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3440
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1390

Total number of triples: 27.